Significantly lower thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) expressions in hG008, GL261 and TSG than in other glioma cells were confirmed by quantitative reverse transcription PCR (Figure S10C). This evidence concerns the gene TYMS and central nervous system cancer.